文献速递消化道出血消化内镜肝病

EUS引导线圈栓塞与BRTO治疗出血性胃静脉曲张的3年结局比较

Bicentric comparison of 3-year clinical outcomes between endoscopic ultrasound-guided embolization with coil and hemostatic adjunct versus balloon-occluded retrograde transvenous obliteration for treatment of bleeding gastric varices: A propensity-score matched study.
PubMed 文献 · Gastrointest Endosc · 2026-10-17

这项双中心回顾性队列研究纳入2009-2024年94例出血性胃静脉曲张患者(EUS-COIL 48例,BRTO 46例),经倾向性评分匹配后分析60例肝硬化患者。EUS-COIL组不良事件更少(3% vs 37%),进一步肝失代偿发生率更低(10% vs 40%),再干预时间更长。

要点

  • 匹配队列中EUS-COIL不良事件显著少于BRTO(3% vs 37%,p=0.003)
  • EUS-COIL组进一步肝失代偿风险更低(HR 0.28,95%CI 0.08-0.984)
  • 未匹配队列中EUS-COIL技术成功率(100% vs 80%)和临床成功率(100% vs 89%)更高

核心结论

  • 在胃静脉曲张出血患者中,EUS-COIL较BRTO技术/临床成功率更高、不良事件更少,且进一步肝失代偿率显著更低。

研究设计与样本

  • 双中心回顾性队列研究,纳入2009-2024年94例因出血性胃静脉曲张接受EUS-COIL(48例)或BRTO(46例)的患者。
  • 对60例肝硬化患者按年龄、性别、Child-Pugh分级、MELD-Na评分和入院血红蛋白进行1:1倾向性评分匹配(每组30例)。
  • 采用时间-事件分析评估干预后36个月结局。

主要发现

  • 匹配队列中技术成功率两组均为100%,临床成功率EUS-COIL 100% vs BRTO 93.3%(p=0.49)。
  • EUS-COIL组不良事件显著更少(3% vs 37%,p=0.003),再干预时间更长(65±52天 vs 10±9.6天,p=0.022),中位随访900±790天。
  • EUS-COIL组进一步肝失代偿发生率更低(10% vs 40%,p=0.007),风险比HR 0.28(95%CI 0.08-0.984,p=0.047)。
  • 匹配队列中术后输血需求、再干预率、住院时间和死亡率无显著差异。
  • 未匹配队列中EUS-COIL技术成功率(100% vs 80%,p=0.001)和临床成功率(100% vs 89%,p=0.03)均高于BRTO。

关键数值与推荐

  • 匹配队列不良事件:EUS-COIL 3% vs BRTO 37%(p=0.003)。
  • 匹配队列进一步肝失代偿:EUS-COIL 10% vs BRTO 40%(p=0.007),HR 0.28(95%CI 0.08-0.984,p=0.047)。
  • 未匹配队列技术成功率:EUS-COIL 100% vs BRTO 80%(p=0.001);临床成功率:100% vs 89%(p=0.03)。

临床怎么用

  • 在具备条件时,EUS-COIL可作为出血性胃静脉曲张的优选初始治疗,纳入阶梯治疗策略。
  • EUS-COIL可能降低长期肝失代偿风险,但需更大规模前瞻性研究验证。

局限性

  • 回顾性研究设计,样本量较小(匹配后每组30例)。
  • 仅纳入两家三级中心患者,可能存在选择偏倚。
  • 作者指出需更大规模前瞻性研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic ultrasound-guided coil injection (EUS-COIL) and balloon-occluded retrograde transvenous obliteration (BRTO) performed by interventional radiology (IR) are both effective obliterative procedures to treat gastric varices. Comparative studies are lacking. Our aim was to assess clinical outcomes for EUS-COIL versus BRTO for treatment of acute gastric variceal bleeding. METHODS: This retrospective cohort study included all patients admitted to two tertiary care centers between 2009-2024 who underwent either EUS-COIL or BRTO for bleeding gastric varices. The primary outcomes were technical/clinical success and adverse events. Secondary outcomes included transfusions, reintervention, length of hospital stay, further hepatic decompensation (esophageal variceal hemorrhage, new ascites, or new hepatic encephalopathy (HE)), and all-cause mortality. Subgroup analyses were performed in patients with cirrhosis, including with propensity score matching (PSM) which was conducted 1:1 for age, sex, Child-Pugh classification, MELD-Na score, and hemoglobin level on admission. Outcomes over the 36-months post-intervention were assessed using time-to-event analysis. RESULTS: A total of 94 patients were included (48 EUS-COIL, 46 BRTO), of whom 60 patients with cirrhosis (30 per group) were analyzed after propensity score matching. In the matched cohort, technical success was 100% in both groups and clinical success was 100% versus 93.3% (p=0.49). The EUS-COIL group experienced significantly fewer adverse events (3% vs 37%; p=0.003) and had a longer time-to-reintervention (65 ± 52 days vs 10 ± 9.6 days; p=0.022) over a median follow-up 900 ± 790 days. The incidence of further hepatic decompensation was lower in the EUS-COIL group (10% vs 40%; p=0.007), as was the likelihood of further hepatic decompensation (HR 0.28 (95%CI: 0.08-0.984), p = 0.047) compared to BRTO. No significant differences were observed with regard to post-procedural transfusion requirements, rates of reintervention, length of hospital stay, and mortality in cirrhosis patients. In the unmatched cohort, technical (100% vs 80%; p=0.001) and clinical (100% vs 89%; p=0.03) success were higher with EUS-COIL than BRTO. CONCLUSIONS: In patients with gastric variceal hemorrhage, EUS-COIL demonstrated higher rates of technical/clinical success and lower rates of adverse events (both peri-procedural and on long-term follow-up) compared to BRTO. EUS-COIL had significantly lower rates of further hepatic decompensation. While larger prospective studies are required, these data suggest that EUS-COIL, when available, may be the preferred initial therapy for bleeding gastric varices as part of a step-up strategy.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Siranart N, Wang TJ, Konyn P, et al. Bicentric comparison of 3-year clinical outcomes between endoscopic ultrasound-guided embolization with coil and hemostatic adjunct versus balloon-occluded retrograde transvenous obliteration for treatment of bleeding gastric varices: A propensity-score matched study. Gastrointest Endosc. 2026. PMID: 42892545. doi:10.1016/j.gie.2026.10.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。